CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells | |
Guo Zhaoming; Liu Ye; Zhou Hao; Zheng Kun; Wang Dong; Jia Mingli; Xu Pengcheng; Ma Kun; Cui Changhao; Wang Li | |
刊名 | Colloids and surfaces. B, Biointerfaces |
2019 | |
卷号 | 184页码:110546 |
关键词 | Bi(2)Se(3) nanoparticles,CD47,Immunotherapy,Macrophage phagocytosis,Photothermal therapy |
ISSN号 | 1873-4367 |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3227847 |
专题 | 大连理工大学 |
作者单位 | 1.School of Life Science and Medicine, Dalian University of Technology, Panjin, Liaoning 124221, China. Electronic address: guozm@dlut.edu.cn. 2.School of Life Science and Medicine, Dalian University of Technology, Panjin, Liaoning 124221, China. 3.School of Food and Environment, Dalian University of Technology, Panjin, Liaoning 124221, China. 4.Panjin People's Hospital, Panjin, Liaoning 124221, China. 5.College of Pharmacy, Inner Mongolia Medical University, Hohhot, Inner Mongolia 010110, China. 6.School of Life Science and Medicine, Dalian University of Technology, Panjin, Liaoning 124221, China. Electronic address: wang_li@dlut.edu.cn. |
推荐引用方式 GB/T 7714 | Guo Zhaoming,Liu Ye,Zhou Hao,et al. CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells[J]. Colloids and surfaces. B, Biointerfaces,2019,184:110546. |
APA | Guo Zhaoming.,Liu Ye.,Zhou Hao.,Zheng Kun.,Wang Dong.,...&Wang Li.(2019).CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.Colloids and surfaces. B, Biointerfaces,184,110546. |
MLA | Guo Zhaoming,et al."CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells".Colloids and surfaces. B, Biointerfaces 184(2019):110546. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论